Cargando…
Intrinsic Class D β-Lactamases of Clostridium difficile
Clostridium difficile is the causative agent of the deadly C. difficile infection. Resistance of the pathogen to β-lactam antibiotics plays a major role in the development of the disease, but the mechanism of resistance is currently unknown. We discovered that C. difficile encodes class D β-lactamas...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299217/ https://www.ncbi.nlm.nih.gov/pubmed/30563905 http://dx.doi.org/10.1128/mBio.01803-18 |
_version_ | 1783381435567046656 |
---|---|
author | Toth, Marta Stewart, Nichole K. Smith, Clyde Vakulenko, Sergei B. |
author_facet | Toth, Marta Stewart, Nichole K. Smith, Clyde Vakulenko, Sergei B. |
author_sort | Toth, Marta |
collection | PubMed |
description | Clostridium difficile is the causative agent of the deadly C. difficile infection. Resistance of the pathogen to β-lactam antibiotics plays a major role in the development of the disease, but the mechanism of resistance is currently unknown. We discovered that C. difficile encodes class D β-lactamases, i.e., CDDs, which are intrinsic to this species. We studied two CDD enzymes, CDD-1 and CDD-2, and showed that they display broad-spectrum, high catalytic efficiency against various β-lactam antibiotics, including penicillins and expanded-spectrum cephalosporins. We demonstrated that the cdd genes are poorly expressed under the control of their own promoters and contribute only partially to the observed resistance to β-lactams. However, when the cdd1 gene was expressed under the control of efficient promoters in the antibiotic-sensitive Clostridium cochlearium strain, it produced high-level resistance to β-lactams. Taken together, the results determined in this work demonstrate the existence in C. difficile of intrinsic class D β-lactamases which constitute a reservoir of highly potent enzymes capable of conferring broad-spectrum, clinically relevant levels of resistance to β-lactam antibiotics. This discovery is a significant contribution to elucidation of the mechanism(s) of resistance of the clinically important pathogen C. difficile to β-lactam antibiotics. |
format | Online Article Text |
id | pubmed-6299217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-62992172018-12-28 Intrinsic Class D β-Lactamases of Clostridium difficile Toth, Marta Stewart, Nichole K. Smith, Clyde Vakulenko, Sergei B. mBio Research Article Clostridium difficile is the causative agent of the deadly C. difficile infection. Resistance of the pathogen to β-lactam antibiotics plays a major role in the development of the disease, but the mechanism of resistance is currently unknown. We discovered that C. difficile encodes class D β-lactamases, i.e., CDDs, which are intrinsic to this species. We studied two CDD enzymes, CDD-1 and CDD-2, and showed that they display broad-spectrum, high catalytic efficiency against various β-lactam antibiotics, including penicillins and expanded-spectrum cephalosporins. We demonstrated that the cdd genes are poorly expressed under the control of their own promoters and contribute only partially to the observed resistance to β-lactams. However, when the cdd1 gene was expressed under the control of efficient promoters in the antibiotic-sensitive Clostridium cochlearium strain, it produced high-level resistance to β-lactams. Taken together, the results determined in this work demonstrate the existence in C. difficile of intrinsic class D β-lactamases which constitute a reservoir of highly potent enzymes capable of conferring broad-spectrum, clinically relevant levels of resistance to β-lactam antibiotics. This discovery is a significant contribution to elucidation of the mechanism(s) of resistance of the clinically important pathogen C. difficile to β-lactam antibiotics. American Society for Microbiology 2018-12-18 /pmc/articles/PMC6299217/ /pubmed/30563905 http://dx.doi.org/10.1128/mBio.01803-18 Text en Copyright © 2018 Toth et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Toth, Marta Stewart, Nichole K. Smith, Clyde Vakulenko, Sergei B. Intrinsic Class D β-Lactamases of Clostridium difficile |
title | Intrinsic Class D β-Lactamases of Clostridium difficile |
title_full | Intrinsic Class D β-Lactamases of Clostridium difficile |
title_fullStr | Intrinsic Class D β-Lactamases of Clostridium difficile |
title_full_unstemmed | Intrinsic Class D β-Lactamases of Clostridium difficile |
title_short | Intrinsic Class D β-Lactamases of Clostridium difficile |
title_sort | intrinsic class d β-lactamases of clostridium difficile |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299217/ https://www.ncbi.nlm.nih.gov/pubmed/30563905 http://dx.doi.org/10.1128/mBio.01803-18 |
work_keys_str_mv | AT tothmarta intrinsicclassdblactamasesofclostridiumdifficile AT stewartnicholek intrinsicclassdblactamasesofclostridiumdifficile AT smithclyde intrinsicclassdblactamasesofclostridiumdifficile AT vakulenkosergeib intrinsicclassdblactamasesofclostridiumdifficile |